#1
|
|||
|
|||
óðåàïëàçìà+ÖÌÂ
Çäðàâñòâóéòå ãëóáîêîóâàæàåìûå!
Ó ìåíÿ òàêàÿ ïðîáëåìà.Ïðèìåðíî 1.5 ãîäà íå ìîãëà çàáåðåìåíåòü.Íî êîãäà âñå-òàêè çàáåðåìåíåëà, áåðåìåííîñòü çàìåðëà ïðèáëèçèòåëüíî íà 6-7 íåäåëå.Ïîñëå îáñëåäîâàíèÿ íàøëè óðåàïëàçìó óðåàëèòèêóì êîëè÷åñòâî âûøå íîðìû, öèòîìåãàëîâèðóñ IgG ïîëîæèòåëüíûé, íî êîëè÷åñòâåííî ìåíüøå ÷åì ïîëîæèòåëüíûé, ò.å.â íåàêòèâíîé ôîðìå.Äî áåðåìåííîñòè ìåíÿ ïðîâåðÿëè íà öèòîìåãàëîâèðóñ è âèðóñ ãåðïåñà è â êðîâè êîëè÷åñòâî áûëî íåìíîãî âûøå íîðìû. Ãèíåêîëîã íàçíà÷èëà ìíå ëå÷åíèå: Þíèäîêñ ïî 1 òàá.2 ð/ä, òðèõîïîë ïî 2 òàá.2 ð/ä.Èíôåêöèîíèñò íàçíà÷èëà Âàëòðåêñ ïî 1 êàïñ.2 ð/ä + ñäàòü èììóíîãðàììó. Äîñòàòî÷íî ëè òàêîãî ëå÷åíèÿ?È åùå îäèí âîïðîñ-ýòà ñõåìà êîòîðóþ íàçíà÷èë ãèíåêîëîã ìíå íå ïîøëà, ò.å.ìîé îðãàíèçì íå âûäåðæàë .Ñóùåñòâóþò ëè àëüòåðíàòèâíûå ñõåìû, êîòîðûå áû íå âûçûâàëè òàêóþ ñèëüíóþ òîøíîòó?  äàííûé ìîìåíò ÿ ïðèíèìàþ Âàëòðåêñ è íà äíÿõ ïîëó÷ó ðåçóëüòàòû èììóííîãðàììû. Ïîæàëóéñòà îòâåòüòå ìíå!...Çàðàíåå áëàãîäàðíà! |
#2
|
|||
|
|||
+ íà ÓÇÈ ïîñòàâèëè äèàãíîç õð.ýíäîìåòðèò, ýíäîìåòðèîç òåëà ìàòêè?.
|
#3
|
||||
|
||||
Sita,
Åñëè Þíèäîêñîì (Doxycycline) âàì ëå÷àò óðåàïëàçìó, òî êðîìå äîêñèöèêëèíà, êîòîðûé âû ïëîõî ïåðåíîñèòå, óðåàïëàçìà ÷óâñòâèòåëüíà, íàïðèìåð, ê àçèòðîìèöèíó (Azithromycin, Zithromax, ñóìàìåä). 1ã àçèòðîìèöèíà îäíîêðàòíî. ×òî âàì ëå÷àò Âàëüòðåêñîì íåïîíÿòíî. Èììóíîãðàììà - èññëåäîâàíèå äëÿ âàñ ñîâåðøåííî áåññìûñëåííîå. Ñèòà, åñëè íå îøèáàþñü, âû áåç ïÿòè ìèíóò âðà÷, âåðíî? |
#4
|
|||
|
|||
â îïèñàííîì âàìè ñëó÷àå íè ïëàíèðóåìîå èññëåäîâàíèå íè ëå÷åíèå íå ÿâëÿåòñÿ îáîñíîâàííûì
|
#5
|
|||
|
|||
Ñîãëàñåí ïî ïîâîäó íåóäà÷íîãî âûáîðà ëå÷åíèÿ è îáñëåäîâàíèÿ. Òðåáóåòñÿ àäåêâàòíûé êóðñ ëå÷åíèÿ íàïðàâëåííûé, êàê íà ýíäîìåòðèò, òàê è íà ýíäîìåòðèîç. À ýòî ïîäðàçóìåâàåò êàê àíòèáèîòèêîòåðàïèþ, òàê è ãîðìîíàëüíóþ òåðàïèþ.
|
#6
|
||||
|
||||
Ïëàíèðóåìàÿ áåðåìåííîñòü ÿâëÿåòñÿ ñîñòîÿíèåì,êîãäà åñòü îñíîâàíèå ïðîâîäèòü ëå÷åíèå íîñèòåëüñòâà óðåàìèêîïëàçì,îñîáåííî ïðè îòÿãîùåííîì àíàìíåçå.Ññûëêè íà îòå÷åñòâåííûå è çàðóáåæíûå èñòî÷íèêè î íåãàòèâíîì äåéñòâèè óðåàìèêîïëàçì íà òå÷åíèå áåðåìåííîñòè,ïëîä è íîâîðîæäåííûõ çäåñü:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ÖÌÂ,äàæå åñëè îí èìååòñÿ-÷òî âûçûâàåò áîëüøèå ñîìíåíèÿ,íèêàêèì ÂÀËÒÐÅÊÑÎÌ íå èçëå÷èøü.Èññëåäîâàíèå èììóíèòåòà â äàííîì ñëó÷àå - òðàòà âðåìåíè è äåíåã. Ïîáî÷íûå ÿâëåíèÿ ìîãóò áûòü ñâÿçàíû ñ ïðèåìîì ìåòðîíèäàçîëà (ïðè ëå÷åíèè íîñèòåëüñòâà óðåàïëàçì îí àáñîëþòíî íå ýôôåêòèâåí). 1 ãðàìì àçèòðîìèöèíà îäíîêðàòíî - èçëå÷èâàåò óðåòðèò íåäåëüíîé äàâíîñòè ñâÿçàííûé ñ óðåàïëàçìîé ó ìóæ÷èí,.Íå âèäåë åùå íè îäíîãî ñëó÷àÿ èçëå÷åíèÿ ïðè íîñèòåëüñòâå óðåàïëàçì ó æåíùèí ïðè ïðèìåíåíèè ýòîé ñõåìû. |
#7
|
||||
|
||||
Ïðîøó ïðîøåíèÿ çà óïîìèíàíèå îäíîêðàòíîãî àçèòðîìèöèíà ïðè ëå÷åíèè óðåàïëàçìû. Íàâåðíîå âû ïðàâû, òàê ëå÷àò óðåòðèò, âûçâàííûé óðåàïëàçìîé.  ÑØÀ êàê-òî íå ïðèäàåòñÿ ïîêà çíà÷åíèÿ áåññèìïòîìíîìó íîñèòåëüñòâó óðåàïëàçìû è ñêðèíèíã áåðåìåííûõ íà óðåàïëàçìó è ëå÷åíèå íîñèòåëüñòâà, íàñêîëüêî ÿ çíàþ, íå ïðîâîäèòñÿ.
Ó Ñèòû äëèííàÿ èñòîðèÿ, êîòîðóþ îíà èçëîæèëà íà Ñîëâåé. Èíòåðåñíî, íàñêîëüêî îïðàâäàí äèàãíîç õðîíè÷eñêîãî ýíäîìåòðèòà è ýíäîìåòðèîçà ó ìîëîäîé áåññèìïòîìíîé äåâóøêè ïîñòàâëåííûé ïî ÓÇÈ? |
|
#8
|
||||
|
||||
Öèòàòà:
|
#9
|
|||
|
|||
Ìèëûå äîêòîðà!!!
ß óæå íåçíàþ ÷òî äåëàòü...Íå õîäèòü ê âðà÷ó?Èëè ÷òî? |
#10
|
||||
|
||||
Ê âðà÷ó, íàçíà÷àþùåìó èììóíîãðàììû è Âàëüòðåõ òî÷íî õîäèòü íå íàäî.
Ñåé÷àñ âàñ ÷òî-íèáóäü áåñïîêîèò? ÒÒà - â íîðìå? |
#11
|
||||
|
||||
Antibiotics for ureaplasma in the vagina in pregnancy.
Cochrane Database Syst Rev. 2004; (1):CD003767 (ISSN: 1469-493X) Raynes-Greenow CH; Roberts CL; Bell JC; Peat B; Gilbert GL Centre for Perinatal Health Services Research, University of Sydney, QE 11 Research Institute, Building DO2, Sydney, New South Wales, Australia. BACKGROUND: Preterm birth is a significant obstetric problem in high-income countries. Genital infection including ureaplasmas are suspected of playing a role in preterm birth and preterm rupture of the membranes. Antibiotics are used to treat women with preterm prelabour rupture of the membranes and results in prolongation of pregnancy and lowers the risks of maternal and neonatal infection. However, antibiotics may be beneficial earlier in pregnancy to eradicate potentially causative agents. OBJECTIVES: The objective of this review is to assess whether antibiotic treatment of pregnant women with ureaplasma in the vagina reduces the incidence of preterm birth and other adverse pregnancy outcomes. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group trials register (April 2003). SELECTION CRITERIA: All randomised controlled trials that compared any antibiotic regimen with placebo or no treatment in pregnant women with ureaplasma detected in the vagina. DATA COLLECTION AND ANALYSIS: Three reviewers independently assessed eligibility and trial quality and extracted data. MAIN RESULTS: One trial involving 1071 women was included. Of these, 644 randomly received antibiotic treatment (174 erythromycin estolate, 224 erythromycin sterate, and 246 clindamycin hydrochloride) and 427 received placebo. This trial did not report data on preterm birth. Incidence of low birthweight less than 2500 grams was only evaluated for erythromycin (combined) (n = 398 ) compared to placebo (n = 427) and there was no statistically significant difference between those treated and those not treated (relative risk (RR) 0.70, 95% confidence interval (CI) 0.46 to 1.07). In regards to side-effects sufficient to stop treatment, data were available for all women, and there were no statistically significant differences between any antibiotic (combined) and the placebo group (RR 1.25, 95% CI 0.85 to 1.85). REVIEWER'S CONCLUSIONS: There is insufficient evidence to show whether giving antibiotics to women with ureaplasma in the vagina will prevent preterm birth. |
#12
|
|||
|
|||
Ìåíÿ íè÷åãî íå áåñïîêîèò.Òîëüêî â ýòîì öèêëå èíîãäà íåïðèÿòíûå îùóùåíèÿ âíèçó æèâîòà.Òàîêå îùóùåíèå ÷òî âñå íà÷àëîñü ïîñëå ïðèåìà àíòèáèîòèêîâ.À òàê, âûäåëåíèé îáèëüíûõ íåò.À âîò íà ÒÒà íå îáñëåäîâàëàñü.
Ïîæàëóéñòà, îáúÿñíèòå, êàêèå ìåäèöèíñêèå ïîêàçàíèÿ äëÿ îáñëåäîâàíèÿ óðîâíÿ ÒÒã â êðîâè? |
#13
|
||||
|
||||
Óâàæàåìàÿ Ñèòà, ó æåíùèí äàæå ñ ñóáêëèíè÷åñêèì (íå ãîâîðÿ î ìàíèôåñòíîì) ãèïîòèðåîçîì ñíèæåíà ôåðòèëüíîñòü è ïîâûøåíû ðèñêè íåáëàãîïîëó÷íûõ èñõîäîâ ïðè áåðåìåííîñòè. Ãèïîòèðåîç ìîæåò ïðîòåêàòü ñîâåðøåííî áåññèìïòîìíî, åñëè æå åñòü êëèíèêà - îíà âñå ðàâíî íåñïåöèôè÷íà. Òèðåîòîêñèêîç - òîæå íå ïîäàðîê, õîòÿ è â ìåíüøåé ñòåïåíè, íî êëèíèêà îáû÷íî âñå æå èìååòñÿ.
Ïîñêîëüêî ïðîâåðèòü ôóíêöèþ ùèòîâèäíîé æåëåçû î÷åíü ïðîñòî, à ðàñïðîñòðàíåííîñòü ïðîáëåì â ýòîé ñôåðå ñðåäè æåíùèí ôåðòèëüíîãî âîçðàñòà äîâîëüíî âûñîêà, òî âñåì æåíùèíàì, èìåâøèì òðóäíîñòè ñ çà÷àòèåì, ëèáî íåáëàãîïîëó÷íûå èñõîäû ïðè ïðåäûäóùèì áåðåìåííîñòÿì, ïðè ïëàíèðîâàíèè ñëåäóþùåé ðåêîìåíäóåòñÿ èññëåäîâàíèå êðîâè íà ÒÒÃ.
__________________
Àííà, âðà÷-ýíäîêðèíîëîã Âîðîíåæ, êëèíèêà Íåïëàöåáî |
#14
|
||||
|
||||
Ñèòà, õî÷ó òîëüêî äîáàâèòü, ÷òî è ñóáêëèíè÷åñêèé è ìàíèôåñòíûé ãèïîòèðåîç î÷åíü ëåãêî êîìïåíñèðóåòñÿ. Ïîýòîìó, åñëè ïðîáëåìà â ýòîì, åå ïðåäåëüíî ïðîñòî óñòðàíèòü.
|
#15
|
|||
|
|||
Òàê è ñäåëàþ!!!!Êàê ïîëó÷ó ðåçóëüòàòû, ñðàçó âàì íàïèøó!
|